August 31, 2017 / 4:56 PM / 4 months ago

BRIEF-AB Science net loss narrows to 13.5 million euros

Aug 31 (Reuters) - AB SCIENCE SA:

* NET LOSS OF 13.5MEUR IN FIRST HALF OF 2017, A DECREASE OF 8.4% AS COMPARED WITH FIRST HALF OF 2016 (14.7MEUR )

* CASH POSITION OF 49.3MEUR AS OF 30 JUNE 2017, PLUS 6.9MEUR OF 2016 TAX CREDIT TO BE REIMBURSED BY PUBLIC FINANCE DEPARTMENT

* PHASE 2/3 STUDY AB10015 OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) MET ITS PRE-SPECIFIED PRIMARY ENDPOINT, WHICH CONFIRMS INTERIM ANALYSIS

* COMPANY TURNOVER AMOUNTS TO 842 K€ FOR THE FIRST HALF OF 2017, AS COMPARED WITH 772 K€ ONE YEAR EARLIER

* OPERATING LOSS AS AT 30 JUNE 2017 AMOUNTED TO 13,709 K€ AS COMPARED WITH 16,099 K€ AS AT 30 JUNE 2016 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below